Predictive modelling to optimise phage intervention against Campylobacter in poultry

Lead Research Organisation: University of Nottingham
Department Name: Sch of Biosciences

Abstract

Campylobacter jejuni and C. coli are bacteria that cause are human food-borne infections through out the world. In common with other European countries, campylobacters are the most commonly recorded cause of acute bacterial enteritis in the UK with 57,772 cases of campylobacteriosis reported to the Health Protection Agency in 2009. However, due to under-reporting the true incidence could be 8-fold higher with estimated costs to the UK economy approaching £600 million per annum. Birds in general naturally carry the bacteria but it is poultry that act as a major vehicle for the infection of the humans through undercooked meat or cross-contamination of other foods in the kitchen. This project will investigate use bacteriophage as a sustainable form of biocontrol against Camplyobacter colonizing and contaminating poultry and poultry meat. Bacteriophage, often simply called phage, are viruses that kill bacteria. Phage are quite specific, they will only affect the target bacteria and not other bacterial flora. They are also common in the environment such that all people encounter them on a daily basis, which includes their presence on fresh produce. The application of phages to kill campylobacters on chickens therefore represents a natural and sustainable measure to reduce the numbers of the pathogen entering the food chain from this source. The optimal use of phage therapy will require good understanding of phage-Campylobacter interactions at all stages of poultry farming and processing. This proposal will build a comprehensive understanding of Campylobacter-bacteriophage interactions in poultry from colonization of the birds to presentation of the meat at retail. It will combine laboratory work and predictive modelling to design protocols for optimal practical phage therapy.

Technical Summary

The use of bacteriophage targeted against Camplyobacter infection in poultry is a potentially powerful form of biocontrol. Optimal use of phage therapy will require good understanding of phage-Campylobacter interactions at all stages of poultry farming and processing. This proposal will build a uniquely comprehensive understanding of Campylobacter-bacteriophage interactions in poultry from infection to carcass. It will combine laboratory interventions and predictive modelling in three strands. We will: 1. Build a comprehensive understanding of in vivo phage-Campylobacter kinetics in broiler chickens. 2. Determine how post-slaughter kinetics contributes to phage therapy efficacy. 3. Use our predictive models to design protocols for optimal practical phage therapy.

Planned Impact

The current proposal is in response to the BBSRC, Defra and FSA research call in support of policy makers and industry to achieve a reduction in the levels of Campylobacter entering the food chain and thereby the incidence of foodborne Campylobacter enteritis in the UK population. Campylobacters are the most commonly recorded cause of acute bacterial enteritis in the UK with an estimated cost approaching £600 million per annum to the economy. Poultry are a major source of infection and this proposal represents a sustainable intervention to reduce the levels of Campylobacter in broiler chickens and on chicken meat. Potential Beneficiaries 1. The public will benefit through a reduction in the incidence of campylobacteriosis, and therefore reduced morbidity, general improved health and no loss of earnings through illness. 2. Policymakers will benefit on completion of the project by gaining an understanding of how phage therapy can be applied, any constraints on efficacy and how these may relate regulatory issues that are currently in focus with an increasing number of permissions being sought for the application of phage for therapeutic and biosanitization purposes in agriculture and on ready to eat foods. 3. The poultry industry will benefit through the provision of a sustainable intervention against Campylobacter in poultry 4. Agri-food and healthcare industries in general may benefit on completion of the project through the provision of quantitative mathematical models that will predict the phamakinetics of phage in an intestinal environment and beyond 5. The food industry in general will benefit in the long term through increased consumer confidence if the levels of foodborne illness decline

Publications

10 25 50
publication icon
Adriaenssens EM (2012) A suggested new bacteriophage genus: "Viunalikevirus". in Archives of virology

publication icon
Aprea G (2018) Isolation and morphological characterization of new bacteriophages active against Campylobacter jejuni. in American Journal Clinical Microbiology & Antimicrobials

publication icon
Brathwaite KJ (2015) Host adaption to the bacteriophage carrier state of Campylobacter jejuni. in Research in microbiology

publication icon
Connerton PL (2011) Campylobacter bacteriophages and bacteriophage therapy. in Journal of applied microbiology

publication icon
Firlieyanti AS (2016) Campylobacters and their bacteriophages from chicken liver: The prospect for phage biocontrol. in International journal of food microbiology

 
Description Campylobacter jejuni and C. coli are bacteria that cause are human food-borne infections throughout the world. Poultry are a major source of infection through undercooked meat or cross-contamination of other foods in the kitchen. We have found ways of delivering naturally occurring viruses that specifically kill the bacteria and only the target bacteria, in poultry and on poultry meat. We have developed novel approach to evaluate risk reduction in food borne pathogen numbers through the application of bacteriophage during food processing. Mathematical models describing the effects of bacteriophage require the inclusion of the non-linear interaction between bacteria and bacteriophage, although these approaches can produce insights into the dynamics of the process, uncertainties in the parameters make the outcomes difficult to estimate.The quality of the fit for many different parameter combinations can be expressed as the likelihood. By repeating the fitting procedure the likelihood functions can be estimated, and by using experimental data to calibrate
the model predictions can then be made from the likelihood surfaces. This procedure will not yield a single value for the prediction of the bacterial load after treatment, but a distribution of values, which tells us the chance that a will we find a certain bacterial load. Based on this distribution we can evaluate the reduced risk associated with the treated product. The approach has the potential to provide a tool to allow faster, cheaper validation and cost-benefit analysis of novel bacteriophage interventions and lower the bar to market entry.
Exploitation Route Commercial companies are using the models and developing delivery protocols for bacteriophage on poultry meat in non-EU countries.
Sectors Agriculture, Food and Drink,Environment,Healthcare,Pharmaceuticals and Medical Biotechnology

 
Description Bacterial infections of man and animals impact directly on human health and food quality. The rise in antibiotic resistance has adversely impacted on our ability to treat these infections. Bacteriophage are naturally occurring viruses that specifically kill target bacteria, and have the potential to be used for therapeutic and food disinfection purposes. We have developed models and application parameters that will assist in the practical application of bacteriophage.
Sector Agriculture, Food and Drink,Healthcare,Pharmaceuticals and Medical Biotechnology
Impact Types Economic

 
Description Development of a Bacteriophage Product to Control Campylobacter Contamination in Kenya
Amount £226,681 (GBP)
Funding ID BB/P02355X/1 
Organisation Biotechnology and Biological Sciences Research Council (BBSRC) 
Sector Public
Country United Kingdom
Start 03/2017 
End 02/2019
 
Title Campylobacter jejuni subsp. jejuni PT14, complete genome. 
Description Genome sequence of universal bacteriophage host strain Campylobacter jejuni subspecies jejuni PT14 
Type Of Material Database/Collection of data 
Year Produced 2012 
Provided To Others? No  
Impact No actual impacts realised to date 
 
Title Campylobacter phage CP30A, complete genome. 
Description Recombination and diversity amongst Campylobacter bacteriophage in chickens. GenBank 
Type Of Material Database/Collection of data 
Year Produced 2012 
Provided To Others? No  
Impact No actual impacts realised to date 
 
Title Campylobacter phage CP8, complete genome 
Description Complete DNA sequnence of the Eucampyviriae used in phage therapy applications. NCBI GenBank 
Type Of Material Database/Collection of data 
Year Produced 2013 
Provided To Others? No  
Impact No actual impacts realised to date 
 
Description Bacteriophage applications in food safety 
Organisation Experimental Zooprophilactic Institute of Campania and Calabria Italy
Country Italy 
Sector Academic/University 
PI Contribution Development of methods for application and scale up
Collaborator Contribution Animal trial facilities
Impact Multi-disciplinary: Microbiology, Quantitative modelling, Veterinary Sciences, Public Health
Start Year 2015
 
Description Modelling pharmakinetics for phage therapy 
Organisation Paul Ehrlich Institute
Country Germany 
Sector Academic/University 
PI Contribution Development of model systems to assess Campylobacter phage replication and production of primary kinetic data.
Collaborator Contribution Extending our existing models of phage dynamics.
Impact At an early stage of the collaboration so no outputs as yet. The collaboration is multidisciplinary with respect to Microbiological data collected in the UK and mathematical approaches adopted in Germany.
Start Year 2018
 
Description Quantitative modelling of phage therapy 
Organisation Royal Holloway, University of London
Country United Kingdom 
Sector Academic/University 
PI Contribution Research collaboration
Start Year 2013
 
Description Use of bacteriophage in prepared foods 
Organisation PTC - Phage Technology Center GmbH
Country Germany 
Sector Private 
PI Contribution Design of experimental trials. Phage discovery and molecular characterisation.
Collaborator Contribution Performing experimental trials. Scale-up of phage production.
Impact Phages 2015: Bacteriophage in Medicine, Food and Biotechnology 01-02 September 2015 St Hilda's College, Oxford, UK Investigation of structures influencing bacteriophage infection of Campylobacter jejuni Lukas Lis1, and Ian F Connerton2 1PTC Phage Technology Center GmbH, Im Kompetenzzentrum BioSecurity, Bönen, Germany 2Division of Food Sciences, School of Biosciences, University of Nottingham, Loughborough, Leicestershire, UK
Start Year 2013
 
Description CHRO 2013: A real time model of in-vivo Campylobacter populations within chicken caeca: applications for bacteriophage host dynamics 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Participants in your research and patient groups
Results and Impact Stimulated interest in research activity.

Limiting the number of parameters and animals in enteric experiments.
Year(s) Of Engagement Activity 2013
 
Description Cafe Scientifique Event 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Public/other audiences
Results and Impact Wide ranging discussion.

Interest in responses antibiotic resistance from public audience.
Year(s) Of Engagement Activity 2015
URL http://www.meetup.com/nottingham-culture-cafe-sci/events/calendar/
 
Description Campylobacter workshop 2013 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Other academic audiences (collaborators, peers etc.)
Results and Impact Discussion with international representatives.

Collaboration
Year(s) Of Engagement Activity 2013
 
Description Public lecture Nottingham: Bacteriophage Control of Bacterial Pathogens: My enemy's enemy is my friend? 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Public/other audiences
Results and Impact Public interest in phage therapy against antibiotic resistant bacteria.

On-line discussions
Year(s) Of Engagement Activity 2013
 
Description Science with Impact - Annual Conference 2015 BSAS & WPSA 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Professional Practitioners
Results and Impact Discussion between a mixed industry and academic audience.

To be confirmed.
Year(s) Of Engagement Activity 2015
URL http://www.bsas.org.uk/events-conferences/annual-conference-2015/